Literature DB >> 3276574

Efficacy of quantitative hepatobiliary scintigraphy and fatty-meal sonography for evaluating patients with suspected partial common duct obstruction.

R M Darweesh1, W J Dodds, W J Hogan, J E Geenen, B D Collier, R Shaker, S M Kishk, E T Stewart, T L Lawson, E H Hassanein.   

Abstract

In this study we evaluated by blinded design the diagnostic efficacy of two noninvasive techniques, quantitative hepatobiliary scintigraphy (QHS) and fatty-meal sonography (FMS), for evaluating patients with suspected partial common duct obstruction. Quantitative hepatobiliary scintigraphy was performed on 56 cholecystectomized individuals (22 asymptomatic controls, 28 patients with suspected partial common duct obstruction, and 6 nonjaundiced cirrhotics) and FMS was done in 51 cases. For QHS, time-activity curves were generated for regions of interest over the liver, hepatic hilum, and common duct. For FMS, we measured common duct diameter before and 45 min after a fatty meal (Lipomul, 1.5 ml/kg). Each of the 28 patients with suspected partial common duct obstruction and 6 cirrhotic patients underwent endoscopic retrograde cholangiography, often accompanied by sphincter of Oddi manometry. Findings from these examinations were taken as the gold standard to determine the presence or absence of conditions that could account for intermittent symptomatic partial common duct obstruction. The most sensitive indicators for a positive test were a 45-min isotope clearance of less than 63% for QHS and a common duct increase of greater than or equal to 2 mm after the fatty meal for FMS. Of 28 patients with suspected partial common duct obstruction, 15 were judged to be true-positive and 13 true-negative. The 6 cirrhotic patients were without common duct obstruction. The study findings showed that each test had a 67% sensitivity that improved to 80% when the findings from both test results were combined. The specificity of QHS was 85% and that of FMS was 100%. All 6 cirrhotic patients had negative findings on FMS and 4 were false-positive on QHS. The true-positives included 8 patients with a small common duct stone and 6 with obstructive sphincter of Oddi dysfunction (4 stenosis, 2 dyskinesia). We conclude that noninvasive QHS and FMS afford good sensitivity and specificity for evaluating cholecystectomized patients with suspected partial common duct obstruction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276574     DOI: 10.1016/0016-5085(88)90254-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

Review 1.  Efficacy of biliary scintigraphy in suspected sphincter of Oddi dysfunction.

Authors:  S Jagannath; A N Kalloo
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  "Characterization of basal hepatic bile...".

Authors:  Harvey A Ziessman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

Review 3.  Biliary scintigraphy versus sphincter of Oddi manometry in patients with post-cholecystectomy pain: is it time to disregard the scan?

Authors:  James Toouli
Journal:  Curr Gastroenterol Rep       Date:  2005-05

Review 4.  Evaluation of the biliary tract in patients with functional biliary symptoms.

Authors:  Peter Funch-Jensen; Asbjørn Mohr Drewes; László Madácsy
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

Review 5.  [Sphincter of Oddi dyskinesia].

Authors:  H-D Allescher
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

6.  Clinical and scintigraphic assessment of the role of endoscopic sphincterotomy in the treatment of sphincter of Oddi dysfunction.

Authors:  G M Fullarton; T Hilditch; A Campbell; W R Murray
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

7.  Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction?

Authors:  Joseph Romagnuolo; Peter B Cotton; Valerie Durkalski; Qi Pauls; Olga Brawman-Mintzer; Douglas A Drossman; Patrick Mauldin; Kyle Orrell; April W Williams; Evan L Fogel; Paul R Tarnasky; Giuseppe Aliperti; Martin L Freeman; Richard A Kozarek; Priya A Jamidar; C Mel Wilcox; Jose Serrano; Grace H Elta
Journal:  Gastrointest Endosc       Date:  2014-01-25       Impact factor: 9.427

8.  Ampulla of Vater/duodenal wall spasm diagnosed by antroduodenal manometry.

Authors:  T Koussayer; T E Ducker; M H Clench; J R Mathias
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

Review 9.  What is sphincter of Oddi dysfunction?

Authors:  J Toouli
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

10.  Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.

Authors:  M S Khuroo; S A Zargar; G N Yattoo
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.